72 Patent Results (46 families)
Make Note

Anti-ccr5 Antibody

  • Published: May 13, 2009
  • Filed: Feb 21, 2003
  • Earliest Priority: Feb 22 2002
  • Family: 29
  • Cited Works: 77
  • Cited by: 0
  • Cites: 15
  • Sequences: 13
  • Additional Info: Cited Works Published Sequence
  • Applicant: Progenics Pharm Inc, Pdl Biopharma Inc
Patent Application
EP 2058006 A1
070-274-962-993-662

Human Immunodeficiency Virus-neutralizing Human Antibodies With Improved Breadth And Potency

  • Published: Jul 28, 2009
  • Filed: Dec 15, 2004
  • Earliest Priority: May 06 2002
  • Family: 12
  • Cited Works: 82
  • Cited by: 1
  • Cites: 25
  • Sequences: 8
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services
  • Applicant: Us Health
Granted Patent
US 7566451 B2
073-517-334-134-077

Carbohydrate-based Synthetic Vaccines For Hiv

  • Published: Jul 7, 2009
  • Filed: Jun 30, 2005
  • Earliest Priority: Oct 11 2002
  • Family: 10
  • Cited Works: 92
  • Cited by: 10
  • Cites: 2
  • Additional Info: Cited Works Full text Published
  • Owner: Maryland Baltimore University Of, University Of Maryland Biotechnology Institute
  • Applicant: Univ Maryland Biotech Inst
Granted Patent
US 7556806 B2
057-366-671-235-199

Monoclonal Antibody Against The Ccr5 Chemokine Receptor

  • Published: Aug 12, 2009
  • Filed: Dec 16, 1999
  • Earliest Priority: Dec 16 1998
  • Family: 22
  • Cited Works: 68
  • Cited by: 0
  • Cites: 0
  • Sequences: 4
  • Additional Info: Cited Works Published Sequence
  • Applicant: Progenics Pharm Inc
Patent Application
EP 2088158 A2
030-010-296-659-557

Hetero-oligomeric Hiv Envelope Proteins

  • Published: Aug 12, 2009
  • Filed: Dec 28, 2005
  • Earliest Priority: Dec 29 2004
  • Family: 13
  • Cited Works: 72
  • Cited by: 0
  • Cites: 9
  • Sequences: 3
  • Additional Info: Cited Works Published Sequence
  • Applicant: Seattle Biomedical Res Inst
Patent Application
EP 2088155 A1
073-284-670-801-890

Enhancing Anti-hiv Efficiency Through Multivalent Inhibitors Targeting Oligomeric Gp120

  • Published: Oct 20, 2009
  • Filed: Feb 9, 2005
  • Earliest Priority: Feb 09 2004
  • Family: 2
  • Cited Works: 35
  • Cited by: 6
  • Cites: 3
  • Sequences: 2
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: University Of Maryland Baltimore, University Of Maryland Biotechnology Institute
  • Applicant: Univ Maryland Biotech Inst
Granted Patent
US 7604804 B2
185-674-975-158-773

B Cell-targeted Toxins For Humoral Immune Response Reduction And Methods Of Use Thereof

Granted Patent
US 7358334 B1
040-241-369-267-169

Glycosylated, Low Antigenicity Low Immunogenicity Factor Viii

Granted Patent
US 6759216 B1
099-130-264-925-275

Broadly Cross-reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By Env-cd4-co-receptor Complexes

Granted Patent
US 7378093 B2
015-193-045-874-333

Adjuvant Compositions

  • Published: Apr 10, 2003
  • Filed: Oct 3, 2002
  • Earliest Priority: Oct 03 2001
  • Family: 17
  • Cited Works: 165
  • Cited by: 54
  • Cites: 77
  • Additional Info: Cited Works Full text Published
  • Applicant: Chiron Corp, O'hagan Derek, Valiante Nicholas
Patent Application
WO 2003/028656 A2
075-888-346-914-500
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback